SCHEMBL28838538

SCHEMBL28838538

O=C(O)CC(C(=O)OC(c1ccccc1)(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.41
GABBR1 Q9UBS5 1/20 0.41
CYP2C19 P33261 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HIF1A Q16665 1/20 0.40
MAPT P10636 2/20 0.38
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
KIF11 P52732 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
PKM P14618 1/20 0.37
EPHX1 P07099 1/20 0.37
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8011431 0.82 MAPT (0.45) GABBR2GABBR1CYP2C19L3MBTL1POLB
SCHEMBL27663392 0.82 MAPT (0.45) GABBR2GABBR1CYP2C19L3MBTL1POLB
SCHEMBL7486608 0.79 KIF11 (0.42) GABBR2GABBR1CYP2C19HIF1AKIF11
SCHEMBL10926391 0.76 GABBR2 (0.46) GABBR2GABBR1CYP2C19L3MBTL1POLB
SCHEMBL6681008 0.76 KMT2A (0.58) GABBR2GABBR1L3MBTL1MAPTALDH1A1
SCHEMBL1545922 0.75 MMP8 (0.53) GABBR2GABBR1ALDH1A1GAASMN1; SMN2
SCHEMBL28851561 0.73 GABBR2 (0.43) GABBR2GABBR1CYP2C19L3MBTL1POLB
SCHEMBL8860352 0.73 GABBR2 (0.43) GABBR2GABBR1CYP2C19L3MBTL1POLB
SCHEMBL377175 0.73 L3MBTL1 (0.61) GABBR2GABBR1CYP2C19L3MBTL1POLB
SCHEMBL146867 0.73 L3MBTL1 (0.61) GABBR2GABBR1CYP2C19L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901690-A Treatment of cancer with Antibody Drug Conjugates (ADCs) that bind 191P4D12 protein 艾更斯司股份有限公司 2022-08-12 CN disclosed